Gibson, Dunn & Crutcher LLP acted for Dianthus Therapeutics, Inc. on its merger with Magenta Therapeutics, Inc., assisted by Goodwin Procter. Magenta Therapeutics, Inc. (Nasdaq: MGTA) and Dianthus Therapeutics,...
Magenta Therapeutics’ Merger with Dianthus Therapeutics
iLearningEngines’ Merger with Arrowroot Acquisition Corp.
Goodwin advised Arrowroot Acquisition Corp. on the deal. Arrowroot Acquisition Corp. (NASDAQ:ARRW) announced its merger agreement with iLearningEngines. Upon closing of the transaction, the combined company will...
Enfusion’s $367 Million IPO
Goodwin advised Enfusion on the deal, while Davis Polk advised the representatives of the several underwriters. Enfusion, Inc. completed its initial public offering of 21,562,500 shares...
Berry Global’s $3,85 Billion Credit Facility
Cahill represented the lead arranger Goldman Sachs in the transaction. Berry Global, Inc. completed the repricing amendment to the its $3,850,000,000 term loan B credit facility. Berry...
Berry Global’s $775 Million Notes Offering
Cahill represented the initial purchasers in the offering. Berry Global, Inc. executed its offering of $775,000,000 aggregate principal amount of 1.57% first priority senior secured notes due...